Summit Therapeutics Appoints Dr. Mostafa Ronaghi, Renowned E

11.04.2024 - Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit,” “we,” or the “Company”) today announced that Mostafa Ronaghi, PhD, has been appointed to its Board of Directors, effective immediately. “We are excited to add Dr. Ronaghi to complement our excellent ... Seite 1

Related Keywords

Stockholm , Sweden , Parallele Biosciences , Maky Zanganeh , Stanford Genome Technology Center , Royal Institute Of Technology , Nasdaq , Team Summit , Leadership Team At Illumina Inc , Executive Board Member , Chief Technology Officer , Senior Vice President , Executive Leadership , Principal Investigator , Nuclear Labs , Royal Institute , Executive Officer , Summit Therapeutics Chart , Ummit Therapeutics Kurs , Ummit Therapeutics Aktie ,